Chemical Properties:
Package: Bottle, Aluminium foil bag, 25kg/Cardboard Drum, or according to customer's requirement Storage Condition: Store in sealed containers at cool and dry place; Protect from light and moistureShanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of 2-Chloromethyl-4-Methoxy-3-Methylpyridine Hydrochloride (CAS: 124473-12-7) with high quality, commercial production. We can provide COA, worldwide delivery, small and bulk quantities available. Please contact: alvin@ruifuchem.com| Item | Specifications |
| Appearance | Off-White to Brown Crystalline Powder |
| Solubility | Freely Soluble in Water; Insoluble in Hexane |
| Identification | HPLC; IR |
| Loss on Drying | <0.50% |
| Purity / Analysis Method | >99.0% (HPLC on dried basis) |
| Single Impurity | <0.50% |
| Total Impurities | <1.00% |
| Test Standard | Enterprise Standard |
| Usage | Intermediate of Ilaprazole (CAS: 172152-36-2) |
Description:
Specifications:
Package & Storage:
| Chemical Name | 2-Chloromethyl-4-Methoxy-3-Methylpyridine Hydrochloride |
| Synonyms | 2-(Chloromethyl)-4-Methoxy-3-Methylpyridine Hydrochloride; 2-Chloromethyl-4-Methoxy-3-Methylpyridine HCl; 2-Chloromethyl-3-Methyl-4-Methoxypyridine Hydrochloride; 2-Chloromethyl-3-Methyl-4-Methoxypyridine HCl; Ilaprazole Intermediate 1 |
| CAS Number | 124473-12-7 |
| CAT Number | RF-PI1853 |
| Stock Status | In Stock, Production Scale Up to Tons |
| Molecular Formula | C8H11Cl2NO |
| Molecular Weight | 208.09 |
| Boiling Point | 257.5±35.0℃ |
| Density | 1.139±0.06 g/cm3 |
| Brand | Ruifu Chemical |
Advantages:
FAQ:
Application:
2-Chloromethyl-4-Methoxy-3-Methylpyridine Hydrochloride (CAS: 124473-12-7) is an intermediate of Ilaprazole (CAS: 172152-36-2). Ilaprazole is a proton pump inhibitor (PPI) used in the treatment of dyspepsia, peptic ulcer disease (PUD), gastroesophageal reflux disease (GORD/GERD) and duodenal ulcer. Clinical studies show that ilaprazole is at least as potent a PPI as omeprazole when taken in equivalent doses. Studies also showed that ilaprazole significantly prevented the development of reflux oesophagitis.
